A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin)First published 17/05/2024 Last updated 17/05/2024 EU PAS number: EUPAS1000000093StudyPlanned